Health Care

Two luxury electric vehicles — the Tesla Model S and the BMW i3 — fell short of getting the highest safety ratings in new crash tests by the insurance industry.

Anthem, which is fighting a U.S. government lawsuit to block its deal to buy Cigna, said quarterly revenue rose 7.6 percent.

Japanese officials have rejected U.S. President Donald Trump's suggestion that Tokyo is seeking to weaken the yen against the U.S. dollar to gain a trade advantage.

Siemens AG, the German maker of gas turbines, trains and medical machines, says net income rose 25 percent to 1.93 billion euros ($2.06 billion) for its most recent quarter.

Pfizer Inc. (PFE) on Tuesday reported fourth-quarter net income of $775 million, after reporting a loss in the same period a year earlier.

Aetna Inc. (AET) on Tuesday reported fourth-quarter earnings of $139 million.

Pfizer Inc. (PFE) Chief Executive Ian Read on Tuesday voiced support for President Donald Trump's calls to add drug manufacturing in the U.S., saying a corporate-tax overhaul would pave the way for Pfizer to add U.S. manufacturing jobs.

U.S. President Donald Trump on Tuesday called on the pharmaceutical industry to boost U.S. production and lower prices, while also vowing to speed up approval times for new medicines and appoint a new U.S. Food and Drug Administration leader soon.

Eli Lilly and Co. on Tuesday reported a surge in fourth-quarter profit on a boost in diabetes treatment sales.

Pfizer, which closed its $14 billion acquisition of Medivation in September, reported a lower-than-expected profit, hit by lower demand for products set to go off patent.

Pfizer, which closed its $14 billion acquisition of Medivation in September, reported a lower-than-expected profit, hit by lower demand for products set to go off patent.

Eli Lilly reported a 7.2 percent rise in quarterly revenue, lifted by higher demand for its diabetes drug Trulicity and other new treatments.

Health insurer Aetna, whose $34 billion deal for Humana was blocked last week, reported a higher-than-expected quarterly profit on Tuesday, helped by higher premiums for its plans.

U.S. President Donald Trump, who has criticized the high prices of prescription drugs, will meet with representatives of the pharmaceutical industry on Tuesday at the White House.

More than 100,000 notebook batteries are being recalled as part of an expanded recall because they can overheat, posing a fire hazard.

Colgate-Palmolive reported an adjusted 4Q profit of $0.75 per share, topping, missing the estimate for $0.75. Revenue for the company came in at $3.72 billion, missing the estimate for $3.86 billion

Federal prosecutors say two owners of psychological service companies have been convicted of an $8.9 million fraud scheme that billed Medicare for unnecessary or nonexistent tests on nursing home patients in four Gulf Coast states.

Johnson & Johnson is buying Swiss biopharmaceutical company Actelion Ltd. for about $30 billion, handing the U.S.-based health care products giant a chance to boost its presence in innovative biotech treatments.

Is getting rid of the ACA as simple as Trump signing his name? Not quite. There are a few problems to consider, one of which it seems is getting overlooked.